158 related articles for article (PubMed ID: 38559366)
1. Engineering luminopsins with improved coupling efficiencies.
Slaviero AN; Gorantla N; Simkins J; Crespo EL; Ikefuama EC; Tree MO; Prakash M; Björefeldt A; Barnett LM; Lambert GG; Lipscombe D; Moore CI; Shaner NC; Hochgeschwender U
Neurophotonics; 2024 Apr; 11(2):024208. PubMed ID: 38559366
[TBL] [Abstract][Full Text] [Related]
2. Engineering luminopsins with improved coupling efficiencies.
Slaviero A; Gorantla N; Simkins J; Crespo EL; Ikefuama EC; Tree MO; Prakash M; Björefeldt A; Barnett LM; Lambert GG; Lipscombe D; Moore CI; Shaner NC; Hochgeschwender U
bioRxiv; 2023 Nov; ():. PubMed ID: 38045286
[TBL] [Abstract][Full Text] [Related]
3. Improved Locomotor Recovery in a Rat Model of Spinal Cord Injury by BioLuminescent-OptoGenetic (BL-OG) Stimulation with an Enhanced Luminopsin.
Ikefuama EC; Kendziorski GE; Anderson K; Shafau L; Prakash M; Hochgeschwender U; Petersen ED
Int J Mol Sci; 2022 Oct; 23(21):. PubMed ID: 36361784
[TBL] [Abstract][Full Text] [Related]
4. Luminopsins integrate opto- and chemogenetics by using physical and biological light sources for opsin activation.
Berglund K; Clissold K; Li HE; Wen L; Park SY; Gleixner J; Klein ME; Lu D; Barter JW; Rossi MA; Augustine GJ; Yin HH; Hochgeschwender U
Proc Natl Acad Sci U S A; 2016 Jan; 113(3):E358-67. PubMed ID: 26733686
[TBL] [Abstract][Full Text] [Related]
5. Bioluminescence-Optogenetics: A Practical Guide.
Stern MA; Skelton H; Fernandez AM; Gutekunst CN; Berglund K; Gross RE
Methods Mol Biol; 2022; 2525():333-346. PubMed ID: 35836081
[TBL] [Abstract][Full Text] [Related]
6. Improved trafficking and expression of luminopsins for more efficient optical and pharmacological control of neuronal activity.
Zhang JY; Tung JK; Wang Z; Yu SP; Gross RE; Wei L; Berglund K
J Neurosci Res; 2020 Mar; 98(3):481-490. PubMed ID: 31670406
[TBL] [Abstract][Full Text] [Related]
7. Defining parameters of specificity for bioluminescent optogenetic activation of neurons using in vitro multi electrode arrays (MEA).
Prakash M; Medendorp WE; Hochgeschwender U
J Neurosci Res; 2020 Mar; 98(3):437-447. PubMed ID: 30152529
[TBL] [Abstract][Full Text] [Related]
8. Novel luciferase-opsin combinations for improved luminopsins.
Park SY; Song SH; Palmateer B; Pal A; Petersen ED; Shall GP; Welchko RM; Ibata K; Miyawaki A; Augustine GJ; Hochgeschwender U
J Neurosci Res; 2020 Mar; 98(3):410-421. PubMed ID: 28862809
[TBL] [Abstract][Full Text] [Related]
9. Step-function luminopsins for bimodal prolonged neuromodulation.
Berglund K; Fernandez AM; Gutekunst CN; Hochgeschwender U; Gross RE
J Neurosci Res; 2020 Mar; 98(3):422-436. PubMed ID: 30957296
[TBL] [Abstract][Full Text] [Related]
10. A New Highly Efficient Molecule for Both Optogenetic and Chemogenetic Control Driven by FRET Amplification of BioLuminescence.
Bjorefeldt A; Murphy J; Crespo EL; Lambert GG; Prakash M; Ikefuama EC; Friedman N; Brown TM; Lipscombe D; Moore CI; Hochgeschwender U; Shaner NC
bioRxiv; 2023 Dec; ():. PubMed ID: 37425735
[TBL] [Abstract][Full Text] [Related]
11. Efficient opto- and chemogenetic control in a single molecule driven by FRET-modified bioluminescence.
Björefeldt A; Murphy J; Crespo EL; Lambert GG; Prakash M; Ikefuama EC; Friedman N; Brown TM; Lipscombe D; Moore CI; Hochgeschwender U; Shaner NC
Neurophotonics; 2024 Apr; 11(2):021005. PubMed ID: 38450294
[TBL] [Abstract][Full Text] [Related]
12. Combined Optogenetic and Chemogenetic Control of Neurons.
Berglund K; Tung JK; Higashikubo B; Gross RE; Moore CI; Hochgeschwender U
Methods Mol Biol; 2016; 1408():207-25. PubMed ID: 26965125
[TBL] [Abstract][Full Text] [Related]
13. Inhibitory luminopsins: genetically-encoded bioluminescent opsins for versatile, scalable, and hardware-independent optogenetic inhibition.
Tung JK; Gutekunst CA; Gross RE
Sci Rep; 2015 Sep; 5():14366. PubMed ID: 26399324
[TBL] [Abstract][Full Text] [Related]
14. A calibrated optogenetic toolbox of stable zebrafish opsin lines.
Antinucci P; Dumitrescu A; Deleuze C; Morley HJ; Leung K; Hagley T; Kubo F; Baier H; Bianco IH; Wyart C
Elife; 2020 Mar; 9():. PubMed ID: 32216873
[TBL] [Abstract][Full Text] [Related]
15. A live cell assay of GPCR coupling allows identification of optogenetic tools for controlling Go and Gi signaling.
Ballister ER; Rodgers J; Martial F; Lucas RJ
BMC Biol; 2018 Jan; 16(1):10. PubMed ID: 29338718
[TBL] [Abstract][Full Text] [Related]
16. Optogenetic Potentials of Diverse Animal Opsins: Parapinopsin, Peropsin, LWS Bistable Opsin.
Koyanagi M; Saito T; Wada S; Nagata T; Kawano-Yamashita E; Terakita A
Adv Exp Med Biol; 2021; 1293():141-151. PubMed ID: 33398811
[TBL] [Abstract][Full Text] [Related]
17. Applications of Bioluminescence-Optogenetics in Rodent Models.
Stern MA; Skelton H; Fernandez AM; Gutekunst CN; Gross RE; Berglund K
Methods Mol Biol; 2022; 2525():347-363. PubMed ID: 35836082
[TBL] [Abstract][Full Text] [Related]
18. BioLuminescent OptoGenetics in the choroid plexus: integrated opto- and chemogenetic control
Klein E; Marsh S; Becker J; Andermann M; Lehtinen M; Moore CI
Neurophotonics; 2024 Apr; 11(2):024210. PubMed ID: 38948888
[TBL] [Abstract][Full Text] [Related]
19. Broad-Band Activatable White-Opsin.
Batabyal S; Cervenka G; Ha JH; Kim YT; Mohanty S
PLoS One; 2015; 10(9):e0136958. PubMed ID: 26360377
[TBL] [Abstract][Full Text] [Related]
20. Non-invasive activation of optogenetic actuators.
Birkner E; Berglund K; Klein ME; Augustine GJ; Hochgeschwender U
Proc SPIE Int Soc Opt Eng; 2014 Feb; 8928():. PubMed ID: 27965518
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
